India’s First Stem Cell Baby at 45: Dr. Sunita Tandulwadkar’s IVF Milestone
At the age of 45, achieving pregnancy can be particularly challenging when ovarian function and ovarian reserve are reduced. In 2018, a remarkable case from India brought attention to an emerging area of reproductive medicine: autologous bone marrow-derived stem cell therapy for ovarian rejuvenation.
The case, reported by Dr. Sunita Rajesh Tandulwadkar and her team, involved a 45-year-old perimenopausal woman who achieved pregnancy through assisted reproduction after undergoing this experimental stem cell-based approach.
A Remarkable Fertility Milestone at 45
The patient was a 45-year-old perimenopausal woman with infrequent menstruation for three years. Her AMH level was 0.4 ng/mL, and ultrasound showed an antral follicle count of one.
She underwent autologous bone marrow-derived stem cell therapy (ABMDSCT) with the aim of supporting ovarian function.
Eight weeks after the procedure, ultrasound showed two follicles in each ovary, while her AMH level had increased to 0.9 ng/mL. The medical team then planned egg retrieval.
IVF and Successful Pregnancy
Three eggs were retrieved, and one Grade A compacting embryo was frozen on day 3.
The patient subsequently underwent frozen embryo transfer. Pregnancy was confirmed, and ultrasound at six weeks showed a single viable intrauterine pregnancy.
The pregnancy progressed without complications, and at 38 weeks, she delivered a 2.7 kg baby girl by Caesarean section. The published report stated that the baby had a good Apgar score and an uneventful neonatal course at the time of reporting.
India’s First Baby Following This Stem Cell Approach
The 2018 medical paper reported this as India’s first baby following autologous stem cell therapy for ovarian rejuvenation.
The authors also stated that, based on the literature available at that time, this may have been the world's first successful application of autologous bone marrow-derived stem cell therapy resulting in a birth in a 45-year-old woman.
This distinction is important. The achievement relates specifically to autologous bone marrow-derived stem cell therapy (ABMDSCT) used for ovarian rejuvenation at age 45, rather than making a broad claim that it was the first baby ever associated with any type of stem-cell-assisted fertility technique.
Dr. Sunita Tandulwadkar’s Contribution to Reproductive Medicine
Dr. Sunita Rajesh Tandulwadkar was one of the authors of the 2018 case report. The publication was associated with the Ruby Hall IVF and Endoscopy Center, Ruby Hall Clinic and Solo Stem Cells, Pune.
Her work in reproductive medicine has included IVF, gynaecological endoscopy and research into emerging approaches for women with reduced ovarian reserve and premature ovarian insufficiency.
Through her work in fertility care, she has also contributed to the development and study of innovative reproductive medicine approaches in Pune. Patients looking for an IVF Clinic in Pune can seek guidance from a qualified reproductive medicine specialist to understand their individual fertility concerns and available options.
What Is Ovarian Rejuvenation?
Ovarian rejuvenation refers to emerging approaches being studied to support ovarian function in women with reduced ovarian reserve or certain fertility challenges.
Autologous stem cell therapy is still an evolving and research-based area. The 2018 paper itself described these applications as being in an early and experimental stage, highlighting the need for further research.
Therefore, stem cell therapy should not be presented as a guaranteed fertility treatment or cure. Treatment suitability and potential outcomes can vary from one patient to another.
Key Facts About the 2018 Case
- Patient age: 45 years
- Patient status: Perimenopausal
- Approach: Autologous bone marrow-derived stem cell therapy
- Purpose: Ovarian rejuvenation
- Eggs retrieved: 3
- Embryo: One Grade A compacting embryo
- Pregnancy: Achieved after frozen embryo transfer
- Delivery: 38 weeks
- Baby: 2.7 kg girl
- Publication: Journal of Human Reproductive Sciences, 2018
Why Was This Case Significant?
The case was significant because it explored an innovative approach for a woman with reduced ovarian function who did not wish to pursue donor-oocyte treatment.
It also brought attention to the potential role of regenerative approaches in reproductive medicine and encouraged further research into ovarian rejuvenation.
However, one successful case does not establish that the treatment will work for every patient. Further research and long-term follow-up are important to understand its effectiveness, limitations and safety.
IVF and Fertility Care in Pune
Fertility challenges can have different causes, and treatment needs to be based on an individual assessment. Depending on age, ovarian reserve, medical history and other fertility factors, a specialist may discuss options such as IVF, fertility-preservation approaches, or other appropriate treatments.
For people exploring IVF Treatment in Pune, consulting an experienced reproductive medicine specialist can help them understand their diagnosis and make informed decisions about their fertility care.
Frequently Asked Questions
Who is Dr. Sunita Tandulwadkar?
Dr. Sunita Tandulwadkar is a reproductive medicine specialist associated with IVF, gynaecological endoscopy and fertility research in Pune.
What happened in the 2018 stem cell baby case?
A 45-year-old perimenopausal woman underwent autologous bone marrow-derived stem cell therapy followed by assisted reproduction and successfully delivered a 2.7 kg baby girl.
Was this India’s first stem cell baby?
The 2018 publication reported it as India’s first baby following this specific autologous stem cell therapy approach for ovarian rejuvenation.
Was it the world's first stem cell baby?
The paper stated that it may have been the world's first successful case of ABMDSCT resulting in birth in a 45-year-old woman. This statement specifically refers to this type of stem cell therapy and the patient's age.
What is ABMDSCT?
ABMDSCT stands for autologous bone marrow-derived stem cell therapy. It refers to the use of stem cells obtained from the patient's own bone marrow.
What is ovarian rejuvenation?
Ovarian rejuvenation refers to emerging approaches being researched to support ovarian function in women with reduced ovarian reserve or related fertility challenges.
Can stem cell therapy guarantee pregnancy?
No. Stem cell-based ovarian therapies are still an evolving area of research, and pregnancy or a successful birth cannot be guaranteed.
Where can I learn about IVF Treatment in Pune?
People considering IVF Treatment in Pune can consult a qualified fertility specialist for an individual evaluation and guidance about suitable treatment options.
How can I choose an IVF Clinic in Pune?
When choosing an IVF Clinic in Pune, patients may consider the clinic's medical expertise, reproductive medicine services, laboratory facilities, treatment approach, and the experience of the fertility specialist.
Conclusion
The 2018 case of a 45-year-old woman achieving pregnancy and delivering a healthy baby following autologous bone marrow-derived stem cell therapy and assisted reproduction represents an important milestone reported in reproductive medicine.
Dr. Sunita Tandulwadkar’s involvement in this case reflects her contribution to exploring innovative approaches in IVF, ovarian rejuvenation, and regenerative reproductive medicine.
For individuals exploring fertility options, an experienced IVF Clinic in Pune can provide personalised evaluation and guidance. If you are considering IVF Treatment in Pune, consult a qualified reproductive medicine specialist to understand the available options and determine which approach may be appropriate for your individual situation.
